Mesenchymal stem cells of dental origin-their potential for anti-inflammatory and regenerative actions in brain and gut damage

Current Neuropharmacology

Volumn 14, Issue 8, 2016, Pages 914-934

  Földes, Anna ^a   Kádár, Kristóf ^a   Kerémi, Beáta ^a   Zsembery, Ákos ^a   Gyires, Klára ^a   Zádori, Zoltán S ^a   Varga, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Alzheimer s disease; CNS damage; Crohn s disease; Dental; Immunomodulation; Inflammation; Inflammatory bowel disease; Mesenchymal stem cells; Multiple sclerosis; Parkinson s disease; Regeneration; Spinal cord injury; Traumatic brain injury; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BRAIN DISEASE; CELL ACTIVATION; CROHN DISEASE; DENDRITIC CELL; DENTAL PULP STEM CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEALING; HUMAN; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PERIODONTAL LIGAMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POLARIZATION; REGENERATION; REGENERATIVE MEDICINE; REGULATORY T LYMPHOCYTE; REVIEW; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; ULCERATIVE COLITIS; ANIMAL; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; MESENCHYMAL STROMA CELL; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TOOTH PULP;

ANIMALS; DENTAL PULP; HUMANS; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVOUS SYSTEM DISEASES; NEUROIMMUNOMODULATION;

EID: 85010369874     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X14666160121115210     Document Type: Review

References (281)

1. Fan, X.; Sun, D.; Tang, X.; Cai, Y.; Yin, Z.Q.; Xu, H. Stem-cell challenges in the treatment of Alzheimer’s disease: a long way from bench to bedside. Med. Res. Rev., 2014, 34(5), 957-978. [http://dx.doi.org/10.1002/med.21309] [PMID: 24500883]
2. Berchtold, N.C.; Cotman, C.W. Evolution in the conceptualization of dementia and Alzheimer’s disease: Greco-Roman period to the 1960s. Neurobiol. Aging, 1998, 19(3), 173-189. [http://dx.doi.org/10.1016/S0197-4580(98)00052-9] [PMID: 9661992]
3. Selkoe, D.J. SnapShot: pathobiology of Alzheimer’s disease. Cell, 2013, 154, 468-468. e461 [http://dx.doi.org/10.1016/j.cell.2013.07. 003]
4. Braak, H.; Braak, E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol., 1991, 82(4), 239-259. [http://dx.doi.org/10.1007/BF00308809] [PMID: 1759558]
5. Wenk, G.L. Neuropathologic changes in Alzheimer’s disease: potential targets for treatment. J. Clin. Psychiatry, 2006, 67(Suppl. 3), 3-7. [PMID: 16649845]
6. Goedert, M.; Strittmatter, W.J.; Roses, A.D. Alzheimer’s disease. Risky apolipoprotein in brain. Nature, 1994, 372(6501), 45-46. [http://dx.doi.org/10.1038/372045a0] [PMID: 7969418]
7. Waring, S.C.; Rosenberg, R.N. Genome-wide association studies in Alzheimer disease. Arch. Neurol., 2008, 65(3), 329-334. [http://dx.doi.org/10.1001/archneur.65.3.329] [PMID: 18332245]
8. Geula, C.; Mesulam, M.M.; Saroff, D.M.; Wu, C.K. Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer disease. J. Neuropathol. Exp. Neurol., 1998, 57(1), 63-75. [http://dx.doi.org/10.1097/00005072-199801000-00008] [PMID: 9600198]
9. Ondrejcak, T.; Klyubin, I.; Hu, N.W.; Barry, A.E.; Cullen, W.K.; Rowan, M.J. Alzheimer’s disease amyloid beta-protein and synaptic function. Neuromolecular Med., 2010, 12(1), 13-26. [http://dx.doi.org/10.1007/s12017-009-8091-0] [PMID: 19757208]
10. Selkoe, D.J. The therapeutics of Alzheimer’s disease: where we stand and where we are heading. Ann. Neurol., 2013, 74(3), 328-336. [http://dx.doi.org/10.1002/ana.24001] [PMID: 25813842]
11. Haas, C. Strategies, development, and pitfalls of therapeutic options for Alzheimer’s disease. J. Alzheimers Dis., 2012, 28(2), 241-281. [PMID: 21987594]
12. Shin, J.Y.; Park, H.J.; Kim, H.N.; Oh, S.H.; Bae, J.S.; Ha, H.J.; Lee, P.H. Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models. Autophagy, 2014, 10(1), 32-44. [http://dx.doi.org/10.4161/auto.26508] [PMID: 24149893]
13. Barage, S.H.; Sonawane, K.D. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer’s disease. Neuropeptides, 2015, 52, 1-18. [http://dx.doi.org/10.1016/j.npep. 2015.06.008] [PMID: 26149638]
14. Agis-Torres, A.; Solhuber, M.; Fernandez, M.; Sanchez-Montero, J.M. Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease. Curr. Neuropharmacol., 2014, 12(1), 2-36. [http://dx.doi.org/10.2174/1570159X113116660047] [PMID: 24533013]
15. Heneka, M.T.; Carson, M.J.; El Khoury, J.; Landreth, G.E.; Brosseron, F.; Feinstein, D.L.; Jacobs, A.H.; Wyss-Coray, T.; Vitorica, J.; Ransohoff, R.M.; Herrup, K.; Frautschy, S.A.; Finsen, B.; Brown, G.C.; Verkhratsky, A.; Yamanaka, K.; Koistinaho, J.; Latz, E.; Halle, A.; Petzold, G.C.; Town, T.; Morgan, D.; Shinohara, M.L.; Perry, V.H.; Holmes, C.; Bazan, N.G.; Brooks, D.J.; Hunot, S.; Joseph, B.; Deigendesch, N.; Garaschuk, O.; Boddeke, E.; Dinarello, C.A.; Breitner, J.C.; Cole, G.M.; Golenbock, D.T.; Kummer, M.P. Neuroinflammation in Alzheimer’s disease. Lancet Neurol., 2015, 14(4), 388-405. [http://dx.doi.org/10.1016/S1474-4422(15)70016-5] [PMID: 25792098]
16. Zhao, P.; Luo, Z.; Tian, W.; Yang, J.; Ibanez, D.P.; Huang, Z.; Tortorella, M.D.; Esteban, M.A.; Fan, W. Solving the puzzle of Parkinson’s disease using induced pluripotent stem cells. Exp. Biol. Med. (Maywood), 2014, 239(11), 1421-1432. [http://dx.doi.org/10. 1177/1535370214538588] [PMID: 24939824]
17. O’Connor, D.M.; Boulis, N.M. Gene therapy for neurodegenerative diseases. Trends Mol. Med., 2015, 21(8), 504-512. [http://dx.doi. org/10.1016/j.molmed.2015.06.001] [PMID: 26122838]
18. Racette, B.A.; Willis, A.W. Time to change the blind men and the elephant approach to Parkinson disease? Neurology, 2015, 85(2), 190-196. [http://dx.doi.org/10.1212/WNL.0000000000001739] [PMID: 26070339]
19. Esposito, E.; Cuzzocrea, S. New therapeutic strategy for Parkinson’s and Alzheimer’s disease. Curr. Med. Chem., 2010, 17 (25), 2764-2774. [http://dx.doi.org/10.2174/092986710791859324] [PMID: 20586718]
20. Wu, X.; Cai, H.; Ge, R.; Li, L.; Jia, Z. Recent progress of imaging agents for Parkinson’s disease. Curr. Neuropharmacol., 2014, 12(6), 551-563. [http://dx.doi.org/10.2174/1570159X13666141204221238] [PMID: 25977680]
21. Holscher, C. New drug treatments show neuroprotective effects in Alzheimer’s and Parkinson’s diseases. Neural Regen. Res., 2014, 9(21), 1870-1873. [http://dx.doi.org/10.4103/1673-5374.145342] [PMID: 25558231]
22. Tanna, T.; Sachan, V. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases. Curr. Stem Cell Res. Ther., 2014, 9(6), 513-521. [http://dx.doi.org/10.2174/1574888X09666140923101110] [PMID: 25248677]
23. Lozano, D.; Gonzales-Portillo, G.S.; Acosta, S.; de la Pena, I.; Tajiri, N.; Kaneko, Y.; Borlongan, C.V. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr. Dis. Treat., 2015, 11, 97-106. [PMID: 25657582]
24. Gennai, S.; Monsel, A.; Hao, Q.; Liu, J.; Gudapati, V.; Barbier, E.L.; Lee, J.W. Cell-based therapy for traumatic brain injury. Br. J. Anaesth., 2015, 115(2), 203-212. [http://dx.doi.org/10.1093/bja/aev229] [PMID: 26170348]
25. Reis, C.; Wang, Y.; Akyol, O.; Ho, W.M.; Ii, R.A.; Stier, G.; Martin, R.; Zhang, J.H. What’s New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment. Int. J. Mol. Sci., 2015, 16(6), 11903-11965. [http://dx.doi.org/10.3390/ijms160611903] [PMID: 26016501]
26. Stocchetti, N.; Taccone, F.S.; Citerio, G.; Pepe, P.E.; Le Roux, P.D.; Oddo, M.; Polderman, K.H.; Stevens, R.D.; Barsan, W.; Maas, A.I.; Meyfroidt, G.; Bell, M.J.; Silbergleit, R.; Vespa, P.M.; Faden, A.I.; Helbok, R.; Tisherman, S.; Zanier, E.R.; Valenzuela, T.; Wendon, J.; Menon, D.K.; Vincent, J.L. Neuroprotection in acute brain injury: an up-to-date review. Crit. Care, 2015, 19, 186. [http://dx.doi.org/10.1186/s13054-015-0887-8] [PMID: 25896893]
27. Tham, S.W.; Palermo, T.M.; Wang, J.; Jaffe, K.M.; Temkin, N.; Durbin, D.; Rivara, F.P. Persistent pain in adolescents following traumatic brain injury. J. Pain, 2013, 14(10), 1242-1249. [http://dx.doi.org/10.1016/j.jpain.2013.05.007] [PMID: 23911979]
28. Acosta, S.A.; Tajiri, N.; Shinozuka, K.; Ishikawa, H.; Sanberg, P.R.; Sanchez-Ramos, J.; Song, S.; Kaneko, Y.; Borlongan, C.V. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One, 2014, 9(3), e90953. [http://dx.doi.org/10. 1371/journal.pone.0090953] [PMID: 24621603]
29. Mayeux, J.P.; Teng, S.X.; Katz, P.S.; Gilpin, N.W.; Molina, P.E. Traumatic brain injury induces neuroinflammation and neuronal degeneration that is associated with escalated alcohol selfadministration in rats. Behav. Brain Res., 2015, 279, 22-30. [http://dx.doi.org/10.1016/j.bbr.2014.10.053] [PMID: 25446758]
30. Katz, P.S.; Sulzer, J.K.; Impastato, R.A.; Teng, S.X.; Rogers, E.K.; Molina, P.E. Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. J. Neurotrauma, 2015, 32(5), 297-306. [http://dx.doi.org/10.1089/neu.2014.3508] [PMID: 25166905]
31. Algattas, H.; Huang, J.H. Traumatic Brain Injury pathophysiology and treatments: early, intermediate, and late phases post-injury. Int. J. Mol. Sci., 2014, 15(1), 309-341. [http://dx.doi.org/10.3390/ijms15010309] [PMID: 24381049]
32. Loane, D.J.; Byrnes, K.R. Role of microglia in neurotrauma. Neurotherapeutics, 2010, 7(4), 366-377. [http://dx.doi.org/10.1016/j.nurt.2010.07.002] [PMID: 20880501]
33. Hernandez-Ontiveros, D.G.; Tajiri, N.; Acosta, S.; Giunta, B.; Tan, J.; Borlongan, C.V. Microglia activation as a biomarker for traumatic brain injury. Front. Neurol., 2013, 4, 30. [http://dx.doi.org/10.3389/fneur.2013.00030] [PMID: 23531681]
34. Pais, T.F.; Figueiredo, C.; Peixoto, R.; Braz, M.H.; Chatterjee, S. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway. J. Neuroinflammation, 2008, 5, 43. [http://dx.doi.org/10.1186/1742-2094-5-43] [PMID: 18844999]
35. Braun, D.; Madrigal, J.L.; Feinstein, D.L. Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications. Curr. Neuropharmacol., 2014, 12(4), 342-352. [http://dx.doi.org/10.2174/1570159X12666140828220938] [PMID: 25342942]
36. Zhang, R.; Liu, Y.; Yan, K.; Chen, L.; Chen, X.R.; Li, P.; Chen, F.F.; Jiang, X.D. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J. Neuroinflammation, 2013, 10, 106. [http://dx.doi.org/10.1186/1742-2094-10-106] [PMID: 23971414]
37. Vawda, R.; Fehlings, M.G. Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives. Curr. Stem Cell Res. Ther., 2013, 8(1), 25-38. [http://dx.doi.org/10.2174/1574888X11308010005] [PMID: 23270635]
38. Yiu, G.; He, Z. Glial inhibition of CNS axon regeneration. Nat. Rev. Neurosci., 2006, 7(8), 617-627. [http://dx.doi.org/10.1038/nrn1956] [PMID: 16858390]
39. Martinez, A.M.; Goulart, C.O.; Ramalho, Bdos.S.; Oliveira, J.T.; Almeida, F.M. Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials. World J. Stem Cells, 2014, 6(2), 179-194. [http://dx.doi.org/10.4252/wjsc. v6.i2.179] [PMID: 24772245]
40. Forostyak, S.; Jendelova, P.; Sykova, E. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications. Biochimie, 2013, 95(12), 2257-2270. [http://dx.doi.org/10.1016/j.biochi.2013.08.004] [PMID: 23994163]
41. Mahad, D.H.; Trapp, B.D.; Lassmann, H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol., 2015, 14(2), 183-193. [http://dx.doi.org/10.1016/S1474-4422(14)70256-X] [PMID: 25772897]
42. Klinker, M.W.; Wei, C.H. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J. Stem Cells, 2015, 7(3), 556-567. [http://dx. doi.org/10.4252/wjsc.v7.i3.556] [PMID: 25914763]
43. Cramer, S.P.; Modvig, S.; Simonsen, H.J.; Frederiksen, J.L.; Larsson, H.B. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis. Brain, 2015, 138(Pt 9), 2571-2583. [http://dx.doi.org/10.1093/brain/awv203] [PMID: 26187333]
44. Stadelmann, C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr. Opin. Neurol., 2011, 24(3), 224-229. [http://dx.doi.org/10.1097/WCO. 0b013e328346056f] [PMID: 21455066]
45. Ng, T.K.; Fortino, V.R.; Pelaez, D.; Cheung, H.S. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J. Stem Cells, 2014, 6(2), 111-119. [http://dx.doi.org/10.4252/wjsc.v6.i2.111] [PMID: 24772238]
46. Kamm, C.P.; Uitdehaag, B.M.; Polman, C.H. Multiple sclerosis: current knowledge and future outlook. Eur. Neurol., 2014, 72(3-4), 132-141. [http://dx.doi.org/10.1159/000360528] [PMID: 25095894]
47. Kawalec, P.; Mikrut, A.; Wiśniewska, N.; Pilc, A. The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis. Curr. Neuropharmacol., 2014, 12(3), 256-268. [http://dx.doi.org/10.2174/1570159X12666140115214801] [PMID: 24851089]
48. O’Connor, K.C.; Bar-Or, A.; Hafler, D.A. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol., 2001, 21(2), 81-92. [http://dx.doi.org/10.1023/A: 1011064007686] [PMID: 11332657]
49. Klaren, R.E.; Motl, R.W.; Woods, J.A.; Miller, S.D. Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis). J. Neuroimmunol., 2014, 274(1-2), 14-19. [http://dx.doi.org/10.1016/j.jneuroim.2014.06.014] [PMID: 24999244]
50. Racz, G.Z.; Kadar, K.; Foldes, A.; Kallo, K.; Perczel-Kovach, K.; Keremi, B.; Nagy, A.; Varga, G. Immunomodulatory and potential therapeutic role of mesenchymal stem cells in periodontitis. J. Physiol. Pharmacol., 2014, 65(3), 327-339. [PMID: 24930504]
51. Loftus, E.V., Jr Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology, 2004, 126(6), 1504-1517. [http://dx.doi.org/10.1053/j.gastro.2004.01.063] [PMID: 15168363]
52. Hendrickson, B.A.; Gokhale, R.; Cho, J.H. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev., 2002, 15(1), 79-94. [http://dx.doi.org/10.1128/CMR.15.1.79-94.2002] [PMID: 11781268]
53. Baumgart, D.C.; Sandborn, W.J. Crohn’s disease. Lancet, 2012, 380(9853), 1590-1605. [http://dx.doi.org/10.1016/S0140-6736(12) 60026-9] [PMID: 22914295]
54. Lakatos, P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J. Gastroenterol., 2006, 12(38), 6102-6108. [http://dx.doi.org/10.3748/wjg.v12.i38.6102] [PMID: 17036379]
55. Cannom, R.R.; Kaiser, A.M.; Ault, G.T.; Beart, R.W., Jr; Etzioni, D.A. Inflammatory bowel disease in the United States from 1998 to 2005: has infliximab affected surgical rates?. Am. Surg., 2009, 75(10), 976-980. [PMID: 19886148]
56. Baumgart, D.C.; Carding, S.R. Inflammatory bowel disease: cause and immunobiology. Lancet, 2007, 369(9573), 1627-1640. [http://dx.doi.org/10.1016/S0140-6736(07)60750-8] [PMID: 17499605]
57. Murphy, S.F.; Kwon, J.H.; Boone, D.L. Novel players in inflammatory bowel disease pathogenesis. Curr. Gastroenterol. Rep., 2012, 14(2), 146-152. [http://dx.doi.org/10.1007/s11894-012-0250-z] [PMID: 22359107]
58. Ordas, I.; Eckmann, L.; Talamini, M.; Baumgart, D.C.; Sandborn, W.J. Ulcerative colitis. Lancet, 2012, 380(9853), 1606-1619. [http://dx.doi.org/10.1016/S0140-6736(12)60150-0] [PMID: 22914296]
59. Gyires, K.; Toth, E.V.; Zadori, S.Z. Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalities. Curr. Pharm. Des., 2014, 20(7), 1063-1081. [http://dx.doi.org/10.2174/13816128113199990417] [PMID: 23782146]
60. Danese, S.; Fiocchi, C. Ulcerative colitis. N. Engl. J. Med., 2011, 365(18), 1713-1725. [http://dx.doi.org/10.1056/NEJMra1102942] [PMID: 22047562]
61. Hardenberg, G.; Steiner, T.S.; Levings, M.K. Environmental influences on T regulatory cells in inflammatory bowel disease. Semin. Immunol., 2011, 23(2), 130-138. [http://dx.doi.org/10.1016/j.smim.2011.01.012] [PMID: 21295492]
62. Dotan, I.; Allez, M.; Nakazawa, A.; Brimnes, J.; Schulder-Katz, M.; Mayer, L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(6), G1630-G1640. [http://dx.doi.org/10.1152/ajpgi.00294.2006] [PMID: 17347451]
63. Powrie, F.; Correa-Oliveira, R.; Mauze, S.; Coffman, R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med., 1994, 179(2), 589-600. [http://dx.doi.org/10.1084/jem.179.2.589] [PMID: 7905019]
64. Xavier, R.J.; Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature, 2007, 448(7152), 427-434. [http://dx.doi.org/10.1038/nature06005] [PMID: 17653185]
65. Brand, S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut, 2009, 58(8), 1152-1167. [http://dx.doi.org/10.1136/gut.2008.163667] [PMID: 19592695]
66. Pene, J.; Chevalier, S.; Preisser, L.; Venereau, E.; Guilleux, M.H.; Ghannam, S.; Moles, J.P.; Danger, Y.; Ravon, E.; Lesaux, S.; Yssel, H.; Gascan, H. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol., 2008, 180(11), 7423-7430. [http://dx.doi.org/10.4049/jimmunol. 180.11.7423] [PMID: 18490742]
67. Saleh, M.; Elson, C.O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity, 2011, 34(3), 293-302. [http://dx.doi.org/10.1016/j.immuni.2011.03.008] [PMID: 21435584]
68. Himmel, M.E.; Yao, Y.; Orban, P.C.; Steiner, T.S.; Levings, M.K. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology, 2012, 136(2), 115-122. [http://dx.doi.org/10.1111/j.1365-2567.2012.03572.x] [PMID: 22348589]
69. Denning, T.L.; Wang, Y.C.; Patel, S.R.; Williams, I.R.; Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol., 2007, 8(10), 1086-1094. [http://dx.doi.org/10.1038/ni1511] [PMID: 17873879]
70. Kamada, N.; Hisamatsu, T.; Okamoto, S.; Sato, T.; Matsuoka, K.; Arai, K.; Nakai, T.; Hasegawa, A.; Inoue, N.; Watanabe, N.; Akagawa, K.S.; Hibi, T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol., 2005, 175(10), 6900-6908. [http://dx.doi.org/10.4049/jimmunol.175.10.6900] [PMID: 16272349]
71. Platt, A.M.; Bain, C.C.; Bordon, Y.; Sester, D.P.; Mowat, A.M. An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation. J. Immunol., 2010, 184(12), 6843-6854. [http://dx.doi.org/10.4049/jimmunol.0903987] [PMID: 20483766]
72. Smythies, L.E.; Sellers, M.; Clements, R.H.; Mosteller-Barnum, M.; Meng, G.; Benjamin, W.H.; Orenstein, J.M.; Smith, P.D. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest., 2005, 115(1), 66-75. [http://dx.doi.org/10.1172/JCI200519229] [PMID: 15630445]
73. Kamada, N.; Hisamatsu, T.; Okamoto, S.; Chinen, H.; Kobayashi, T.; Sato, T.; Sakuraba, A.; Kitazume, M.T.; Sugita, A.; Koganei, K.; Akagawa, K.S.; Hibi, T. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFNgamma axis. J. Clin. Invest., 2008, 118(6), 2269-2280. [PMID: 18497880]
74. Abraham, C.; Medzhitov, R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology, 2011, 140(6), 1729-1737. [http://dx.doi.org/10.1053/j.gastro.2011.02.012] [PMID: 21530739]
75. Banchereau, J.; Steinman, R.M. Dendritic cells and the control of immunity. Nature, 1998, 392(6673), 245-252. [http://dx.doi.org/10. 1038/32588] [PMID: 9521319]
76. Hart, A.L.; Al-Hassi, H.O.; Rigby, R.J.; Bell, S.J.; Emmanuel, A.V.; Knight, S.C.; Kamm, M.A.; Stagg, A.J. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology, 2005, 129(1), 50-65. [http://dx.doi.org/10.1053/j.gastro.2005.05.013] [PMID: 16012934]
77. Geissmann, F.; Manz, M.G.; Jung, S.; Sieweke, M.H.; Merad, M.; Ley, K. Development of monocytes, macrophages, and dendritic cells. Science, 2010, 327(5966), 656-661. [http://dx.doi.org/10.1126/science.1178331] [PMID: 20133564]
78. Varol, C.; Vallon-Eberhard, A.; Elinav, E.; Aychek, T.; Shapira, Y.; Luche, H.; Fehling, H.J.; Hardt, W.D.; Shakhar, G.; Jung, S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity, 2009, 31(3), 502-512. [http://dx.doi.org/10.1016/j.immuni.2009.06.025] [PMID: 19733097]
79. Coombes, J.L.; Siddiqui, K.R.; Arancibia-Carcamo, C.V.; Hall, J.; Sun, C.M.; Belkaid, Y.; Powrie, F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med., 2007, 204(8), 1757-1764. [http://dx.doi.org/10.1084/jem.20070590] [PMID: 17620361]
80. Bogunovic, M.; Ginhoux, F.; Helft, J.; Shang, L.; Hashimoto, D.; Greter, M.; Liu, K.; Jakubzick, C.; Ingersoll, M.A.; Leboeuf, M.; Stanley, E.R.; Nussenzweig, M.; Lira, S.A.; Randolph, G.J.; Merad, M. Origin of the lamina propria dendritic cell network. Immunity, 2009, 31(3), 513-525. [http://dx.doi.org/10.1016/j.immuni.2009. 08.010] [PMID: 19733489]
81. Annacker, O.; Coombes, J.L.; Malmstrom, V.; Uhlig, H.H.; Bourne, T.; Johansson-Lindbom, B.; Agace, W.W.; Parker, C.M.; Powrie, F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med., 2005, 202(8), 1051-1061. [http://dx.doi.org/10.1084/jem.20040662] [PMID: 16216886]
82. Heller, F.; Florian, P.; Bojarski, C.; Richter, J.; Christ, M.; Hillenbrand, B.; Mankertz, J.; Gitter, A.H.; Burgel, N.; Fromm, M.; Zeitz, M.; Fuss, I.; Strober, W.; Schulzke, J.D. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology, 2005, 129(2), 550-564. [http://dx.doi.org/10.1016/j.gastro.2005.05. 002] [PMID: 16083712]
83. Fujino, S.; Andoh, A.; Bamba, S.; Ogawa, A.; Hata, K.; Araki, Y.; Bamba, T.; Fujiyama, Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 2003, 52(1), 65-70. [http://dx. doi.org/10.1136/gut.52.1.65] [PMID: 12477762]
84. Rovedatti, L.; Kudo, T.; Biancheri, P.; Sarra, M.; Knowles, C.H.; Rampton, D.S.; Corazza, G.R.; Monteleone, G.; Di Sabatino, A.; Macdonald, T.T. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut, 2009, 58(12), 1629-1636. [http://dx.doi.org/10.1136/gut.2009. 182170] [PMID: 19740775]
85. Leppkes, M.; Becker, C.; Ivanov, I.I.; Hirth, S.; Wirtz, S.; Neufert, C.; Pouly, S.; Murphy, A.J.; Valenzuela, D.M.; Yancopoulos, G.D.; Becher, B.; Littman, D.R.; Neurath, M.F. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology, 2009, 136(1), 257-267. [http://dx.doi.org/10.1053/j.gastro.2008.10.018] [PMID: 18992745]
86. Hue, S.; Ahern, P.; Buonocore, S.; Kullberg, M.C.; Cua, D.J.; McKenzie, B.S.; Powrie, F.; Maloy, K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med., 2006, 203(11), 2473-2483. [http://dx.doi.org/10.1084/jem.20061099] [PMID: 17030949]
87. Uhlig, H.H.; McKenzie, B.S.; Hue, S.; Thompson, C.; Joyce-Shaikh, B.; Stepankova, R.; Robinson, N.; Buonocore, S.; Tlaskalova-Hogenova, H.; Cua, D.J.; Powrie, F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity, 2006, 25(2), 309-318. [http://dx.doi.org/10.1016/j.immuni.2006.05.017] [PMID: 16919486]
88. Morrissey, P.J.; Charrier, K.; Braddy, S.; Liggitt, D.; Watson, J.D. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med., 1993, 178(1), 237-244. [http://dx.doi.org/10.1084/jem.178.1.237] [PMID: 8100269]
89. Maloy, K.J.; Salaun, L.; Cahill, R.; Dougan, G.; Saunders, N.J.; Powrie, F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med., 2003, 197(1), 111-119. [http://dx.doi.org/10.1084/jem.20021345] [PMID: 12515818]
90. Izcue, A.; Coombes, J.L.; Powrie, F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev., 2006, 212, 256-271. [http://dx.doi. org/10.1111/j.0105-2896.2006.00423.x] [PMID: 16903919]
91. Li, M.O.; Wan, Y.Y.; Sanjabi, S.; Robertson, A.K.; Flavell, R.A. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol., 2006, 24, 99-146. [http://dx.doi.org/10.1146/annurev.immunol.24.021605.090737] [PMID: 16551245]
92. Powrie, F.; Carlino, J.; Leach, M.W.; Mauze, S.; Coffman, R.L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med., 1996, 183(6), 2669-2674. [http://dx.doi.org/10.1084/jem.183.6.2669] [PMID: 8676088]
93. Fahlen, L.; Read, S.; Gorelik, L.; Hurst, S.D.; Coffman, R.L.; Flavell, R.A.; Powrie, F. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med., 2005, 201(5), 737-746. [http://dx.doi.org/10.1084/jem.20040685] [PMID: 15753207]
94. Kullberg, M.C.; Jankovic, D.; Gorelick, P.L.; Caspar, P.; Letterio, J.J.; Cheever, A.W.; Sher, A. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med., 2002, 196(4), 505-515. [http://dx.doi.org/10.1084/jem.20020556] [PMID: 12186842]
95. Grohmann, U.; Orabona, C.; Fallarino, F.; Vacca, C.; Calcinaro, F.; Falorni, A.; Candeloro, P.; Belladonna, M.L.; Bianchi, R.; Fioretti, M.C.; Puccetti, P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol., 2002, 3(11), 1097-1101. [http://dx.doi.org/10.1038/ni846] [PMID: 12368911]
96. Munn, D.H.; Sharma, M.D.; Lee, J.R.; Jhaver, K.G.; Johnson, T.S.; Keskin, D.B.; Marshall, B.; Chandler, P.; Antonia, S.J.; Burgess, R.; Slingluff, C.L., Jr; Mellor, A.L. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science, 2002, 297(5588), 1867-1870. [http://dx.doi.org/10.1126/science.1073514] [PMID: 12228717]
97. Barnes, M.J.; Griseri, T.; Johnson, A.M.; Young, W.; Powrie, F.; Izcue, A. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria. Mucosal Immunol., 2013, 6(2), 324-334. [http://dx.doi.org/10.1038/mi.2012.75] [PMID: 22910217]
98. Bjorklund, L.M.; Sanchez-Pernaute, R.; Chung, S.; Andersson, T.; Chen, I.Y.; McNaught, K.S.; Brownell, A.L.; Jenkins, B.G.; Wahlestedt, C.; Kim, K.S.; Isacson, O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl. Acad. Sci. USA, 2002, 99(4), 2344-2349. [http://dx.doi.org/10.1073/pnas.022438099] [PMID: 11782534]
99. Aboody, K.; Capela, A.; Niazi, N.; Stern, J.H.; Temple, S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone. Neuron, 2011, 70(4), 597-613. [http://dx.doi.org/10.1016/j.neuron.2011.05.007] [PMID: 21609819]
100. Blum, B.; Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res., 2008, 100, 133-158. [http://dx.doi. org/10.1016/S0065-230X(08)00005-5] [PMID: 18620095]
101. Grinnemo, K.H.; Kumagai-Braesch, M.; Mansson-Broberg, A.; Skottman, H.; Hao, X.; Siddiqui, A.; Andersson, A.; Stromberg, A.M.; Lahesmaa, R.; Hovatta, O.; Sylven, C.; Corbascio, M.; Dellgren, G. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod. Biomed. Online, 2006, 13(5), 712-724. [http://dx.doi.org/10.1016/S1472-6483(10)60663-3] [PMID: 17169186]
102. Grinnemo, K.H.; Sylven, C.; Hovatta, O.; Dellgren, G.; Corbascio, M. Immunogenicity of human embryonic stem cells. Cell Tissue Res., 2008, 331(1), 67-78. [http://dx.doi.org/10.1007/s00441-007-0486-3] [PMID: 17846795]
103. Blum, B.; Bar-Nur, O.; Golan-Lev, T.; Benvenisty, N. The antiapoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol., 2009, 27(3), 281-287. [http://dx.doi.org/10.1038/nbt.1527] [PMID: 19252483]
104. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4), 663-676. [http://dx.doi.org/10.1016/j.cell.2006.07.024] [PMID: 16904174]
105. Hacein-Bey-Abina, S.; Garrigue, A.; Wang, G.P.; Soulier, J.; Lim, A.; Morillon, E.; Clappier, E.; Caccavelli, L.; Delabesse, E.; Beldjord, K.; Asnafi, V.; MacIntyre, E.; Dal Cortivo, L.; Radford, I.; Brousse, N.; Sigaux, F.; Moshous, D.; Hauer, J.; Borkhardt, A.; Belohradsky, B.H.; Wintergerst, U.; Velez, M.C.; Leiva, L.; Sorensen, R.; Wulffraat, N.; Blanche, S.; Bushman, F.D.; Fischer, A.; Cavazzana-Calvo, M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 2008, 118(9), 3132-3142. [http://dx.doi.org/10.1172/JCI35700] [PMID: 18688285]
106. Modlich, U.; Baum, C. Preventing and exploiting the oncogenic potential of integrating gene vectors. J. Clin. Invest., 2009, 119(4), 755-758. [http://dx.doi.org/10.1172/JCI38831] [PMID: 19348042]
107. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science, 2008, 322(5903), 949-953. [http://dx.doi.org/10.1126/science.1164270] [PMID: 18845712]
108. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322(5903), 945-949. [http://dx.doi.org/10.1126/science.1162494] [PMID: 18818365]
109. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science, 2009, 324(5928), 797-801. [http://dx.doi.org/10.1126/science.1172482] [PMID: 19325077]
110. Kim, D.; Kim, C.H.; Moon, J.I.; Chung, Y.G.; Chang, M.Y.; Han, B.S.; Ko, S.; Yang, E.; Cha, K.Y.; Lanza, R.; Kim, K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 2009, 4(6), 472-476. [http://dx.doi.org/10.1016/j.stem.2009.05.005] [PMID: 19481515]
111. Vierbuchen, T.; Ostermeier, A.; Pang, Z.P.; Kokubu, Y.; Sudhof, T.C.; Wernig, M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 2010, 463(7284), 1035-1041. [http://dx.doi.org/10.1038/nature08797] [PMID: 20107439]
112. Glowacki, J.; Mizuno, S. Collagen scaffolds for tissue engineering. Biopolymers, 2008, 89(5), 338-344. [http://dx.doi.org/10.1002/bip.20871] [PMID: 17941007]
113. Bianco, P.; Riminucci, M.; Gronthos, S.; Robey, P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19(3), 180-192. [http://dx.doi.org/10.1634/stemcells. 19-3-180] [PMID: 11359943]
114. Prockop, D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997, 276(5309), 71-74. [http://dx.doi.org/10.1126/science.276.5309.71] [PMID: 9082988]
115. Hipp, J.; Atala, A. Sources of stem cells for regenerative medicine. Stem Cell Rev., 2008, 4(1), 3-11. [http://dx.doi.org/10.1007/s12015-008-9010-8] [PMID: 18286392]
116. Vemuri, M.C.; Chase, L.G.; Rao, M.S. Mesenchymal stem cell assays and applications. Methods Mol. Biol., 2011, 698, 3-8. [http://dx.doi.org/10.1007/978-1-60761-999-4_1] [PMID: 21431506]
117. Kuehnle, I.; Goodell, M.A. The therapeutic potential of stem cells from adults. BMJ, 2002, 325(7360), 372-376. [http://dx.doi.org/10.1136/bmj.325.7360.372] [PMID: 12183311]
118. Javazon, E.H.; Beggs, K.J.; Flake, A.W. Mesenchymal stem cells: paradoxes of passaging. Exp. Hematol., 2004, 32(5), 414-425. [http://dx.doi.org/10.1016/j.exphem.2004.02.004] [PMID: 15145209]
119. Le Blanc, K.; Pittenger, M. Mesenchymal stem cells: progress toward promise. Cytotherapy, 2005, 7(1), 36-45. [http://dx.doi.org/10.1016/S1465-3249(05)70787-8] [PMID: 16040382]
120. Gronthos, S.; Mankani, M.; Brahim, J.; Robey, P.G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 2000, 97(25), 13625-13630. [http://dx.doi.org/10.1073/pnas.240309797] [PMID: 11087820]
121. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411), 143-147. [http://dx.doi.org/10.1126/science.284.5411.143] [PMID: 10102814]
122. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, Dj.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006, 8(4), 315-317. [http://dx. doi.org/10.1080/14653240600855905] [PMID: 16923606]
123. Gronthos, S.; Zannettino, A.C.; Hay, S.J.; Shi, S.; Graves, S.E.; Kortesidis, A.; Simmons, P.J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci., 2003, 116(Pt 9), 1827-1835. [http://dx.doi.org/10.1242/jcs.00369] [PMID: 12665563]
124. Martinez, C.; Hofmann, T.J.; Marino, R.; Dominici, M.; Horwitz, E.M. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood, 2007, 109(10), 4245-4248. [http://dx.doi.org/10.1182/blood-2006-08-039347] [PMID: 17264296]
125. Gang, E.J.; Bosnakovski, D.; Figueiredo, C.A.; Visser, J.W.; Perlingeiro, R.C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood, 2007, 109(4), 1743-1751. [http://dx.doi.org/10.1182/blood-2005-11-010504] [PMID: 17062733]
126. Sacchetti, B.; Funari, A.; Michienzi, S.; Di Cesare, S.; Piersanti, S.; Saggio, I.; Tagliafico, E.; Ferrari, S.; Robey, P.G.; Riminucci, M.; Bianco, P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 2007, 131(2), 324-336. [http://dx.doi.org/10.1016/j.cell.2007.08. 025] [PMID: 17956733]
127. Rasmusson, I.; Ringden, O.; Sundberg, B.; Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003, 76(8), 1208-1213. [http://dx.doi. org/10.1097/01.TP.0000082540.43730.80] [PMID: 14578755]
128. Taddio, A.; Biondi, A.; Piscianz, E.; Valencic, E.; Biagi, E.; Badolato, R. From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disorders. Curr. Pharm. Des., 2012, 18(35), 5776-5781. [http://dx. doi.org/10.2174/138161212803530754] [PMID: 22726117]
129. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol., 2002, 30(1), 42-48. [http://dx.doi.org/10.1016/S0301-472X(01)00769-X] [PMID: 11823036]
130. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P.D.; Matteucci, P.; Grisanti, S.; Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99(10), 3838-3843. [http://dx.doi.org/10.1182/blood.V99.10.3838] [PMID: 11986244]
131. Krampera, M.; Glennie, S.; Dyson, J.; Scott, D.; Laylor, R.; Simpson, E.; Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 2003, 101(9), 3722-3729. [http://dx.doi.org/10.1182/blood-2002-07-2104] [PMID: 12506037]
132. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S.E.; Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol., 2003, 57(1), 11-20. [http://dx.doi.org/10.1046/j.1365-3083.2003.01176.x] [PMID: 12542793]
133. Pierdomenico, L.; Bonsi, L.; Calvitti, M.; Rondelli, D.; Arpinati, M.; Chirumbolo, G.; Becchetti, E.; Marchionni, C.; Alviano, F.; Fossati, V.; Staffolani, N.; Franchina, M.; Grossi, A.; Bagnara, G.P. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation, 2005, 80(6), 836-842. [http://dx.doi.org/10.1097/01.tp.0000173794. 72151.88] [PMID: 16210973]
134. Tse, W.T.; Pendleton, J.D.; Beyer, W.M.; Egalka, M.C.; Guinan, E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 2003, 75(3), 389-397. [http://dx.doi.org/10.1097/01.TP.0000045055.63901.A9] [PMID: 12589164]
135. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 2005, 105(5), 2214-2219. [http://dx. doi.org/10.1182/blood-2004-07-2921] [PMID: 15514012]
136. Aggarwal, S.; Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105(4), 1815-1822. [http://dx.doi.org/10.1182/blood-2004-04-1559] [PMID: 15494428]
137. Krampera, M.; Cosmi, L.; Angeli, R.; Pasini, A.; Liotta, F.; Andreini, A.; Santarlasci, V.; Mazzinghi, B.; Pizzolo, G.; Vinante, F.; Romagnani, P.; Maggi, E.; Romagnani, S.; Annunziato, F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells, 2006, 24(2), 386-398. [http://dx.doi.org/10.1634/stemcells.2005-0008] [PMID: 16123384]
138. Meisel, R.; Zibert, A.; Laryea, M.; Gobel, U.; Daubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic Tcell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood, 2004, 103(12), 4619-4621. [http://dx.doi.org/10.1182/blood-2003-11-3909] [PMID: 15001472]
139. Sato, K.; Ozaki, K.; Oh, I.; Meguro, A.; Hatanaka, K.; Nagai, T.; Muroi, K.; Ozawa, K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, 2007, 109(1), 228-234. [http://dx.doi.org/10.1182/blood-2006-02-002246] [PMID: 16985180]
140. Gerdoni, E.; Gallo, B.; Casazza, S.; Musio, S.; Bonanni, I.; Pedemonte, E.; Mantegazza, R.; Frassoni, F.; Mancardi, G.; Pedotti, R.; Uccelli, A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol., 2007, 61(3), 219-227. [http://dx.doi.org/10.1002/ana.21076] [PMID: 17387730]
141. Asari, S.; Itakura, S.; Ferreri, K.; Liu, C.P.; Kuroda, Y.; Kandeel, F.; Mullen, Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol., 2009, 37(5), 604-615. [http://dx. doi.org/10.1016/j.exphem.2009.01.005] [PMID: 19375651]
142. Yadav, P.K.; Chen, C.; Liu, Z. Potential role of NK cells in the pathogenesis of inflammatory bowel disease. J. Biomed. Biotechnol., 2011, 2011, 348530. [http://dx.doi.org/10.1155/2011/348530]
143. Sotiropoulou, P.A.; Perez, S.A.; Gritzapis, A.D.; Baxevanis, C.N.; Papamichail, M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 2006, 24(1), 74-85. [http://dx.doi.org/10.1634/stemcells.2004-0359] [PMID: 16099998]
144. Spaggiari, G.M.; Capobianco, A.; Becchetti, S.; Mingari, M.C.; Moretta, L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 2006, 107(4), 1484-1490. [http://dx.doi.org/10.1182/blood-2005-07-2775] [PMID: 16239427]
145. Shi, M.; Liu, Z.W.; Wang, F.S. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin. Exp. Immunol., 2011, 164(1), 1-8. [http://dx.doi.org/10.1111/j.1365-2249.2011.04327.x] [PMID: 21352202]
146. Jiang, X.X.; Zhang, Y.; Liu, B.; Zhang, S.X.; Wu, Y.; Yu, X.D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 2005, 105(10), 4120-4126. [http://dx.doi.org/10.1182/blood-2004-02-0586] [PMID: 15692068]
147. Zhang, W.; Ge, W.; Li, C.; You, S.; Liao, L.; Han, Q.; Deng, W.; Zhao, R.C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev., 2004, 13(3), 263-271. [http://dx.doi.org/10. 1089/154732804323099190] [PMID: 15186722]
148. Nemeth, K.; Leelahavanichkul, A.; Yuen, P.S.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P.G.; Leelahavanichkul, K.; Koller, B.H.; Brown, J.M.; Hu, X.; Jelinek, I.; Star, R.A.; Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)- dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med., 2009, 15(1), 42-49. [http://dx.doi.org/10.1038/nm.1905] [PMID: 19098906]
149. Del Papa, B.; Sportoletti, P.; Cecchini, D.; Rosati, E.; Balucani, C.; Baldoni, S.; Fettucciari, K.; Marconi, P.; Martelli, M.F.; Falzetti, F.; Di Ianni, M. Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction. Eur. J. Immunol., 2013, 43(1), 182-187. [http://dx.doi.org/10.1002/eji.201242643] [PMID: 23161436]
150. Madec, A.M.; Mallone, R.; Afonso, G.; Abou Mrad, E.; Mesnier, A.; Eljaafari, A.; Thivolet, C. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia, 2009, 52(7), 1391-1399. [http://dx.doi.org/10.1007/s00125-009-1374-z] [PMID: 19421731]
151. Ge, W.; Jiang, J.; Arp, J.; Liu, W.; Garcia, B.; Wang, H. Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3- dioxygenase expression. Transplantation, 2010, 90(12), 1312-1320. [http://dx.doi.org/10.1097/TP.0b013e3181fed001] [PMID: 21042238]
152. Gonzalez, M.A.; Gonzalez-Rey, E.; Rico, L.; Buscher, D.; Delgado, M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum., 2009, 60(4), 1006-1019. [http://dx.doi.org/10.1002/art.24405] [PMID: 19333946]
153. Gonzalez-Rey, E.; Anderson, P.; Gonzalez, M.A.; Rico, L.; Buscher, D.; Delgado, M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut, 2009, 58(7), 929-939. [http://dx.doi.org/10.1136/gut.2008.168534] [PMID: 19136511]
154. Tipnis, S.; Viswanathan, C.; Majumdar, A.S. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunol. Cell Biol., 2010, 88(8), 795-806. [http://dx.doi.org/10.1038/icb.2010.47] [PMID: 20386557]
155. English, K.; Ryan, J.M.; Tobin, L.; Murphy, M.J.; Barry, F.P.; Mahon, B.P. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin. Exp. Immunol., 2009, 156(1), 149-160. [http://dx.doi.org/10.1111/j.1365-2249.2009.03874.x] [PMID: 19210524]
156. Zhang, Q.; Shi, S.; Liu, Y.; Uyanne, J.; Shi, Y.; Shi, S.; Le, A.D. Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammationrelated tissue destruction in experimental colitis. J. Immunol., 2009, 183(12), 7787-7798. [http://dx.doi.org/10.4049/jimmunol.0902318] [PMID: 19923445]
157. Sioud, M.; Mobergslien, A.; Boudabous, A.; Floisand, Y. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation. Scand. J. Immunol., 2010, 71(4), 267-274. [http://dx.doi.org/10.1111/j.1365-3083.2010. 02378.x] [PMID: 20384870]
158. Glenn, J.D.; Whartenby, K.A. Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J. Stem Cells, 2014, 6(5), 526-539. [http://dx.doi.org/10.4252/wjsc.v6.i5. 526] [PMID: 25426250]
159. Krampera, M. Mesenchymal stromal cell ‘licensing’: a multistep process. Leukemia, 2011, 25(9), 1408-1414. [http://dx.doi.org/10.1038/leu.2011.108] [PMID: 21617697]
160. Pluchino, S.; Cossetti, C. How stem cells speak with host immune cells in inflammatory brain diseases. Glia, 2013, 61(9), 1379-1401. [http://dx.doi.org/10.1002/glia.22500] [PMID: 23633288]
161. Blurton-Jones, M.; Kitazawa, M.; Martinez-Coria, H.; Castello, N.A.; Muller, F.J.; Loring, J.F.; Yamasaki, T.R.; Poon, W.W.; Green, K.N.; LaFerla, F.M. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc. Natl. Acad. Sci. USA, 2009, 106(32), 13594-13599. [http://dx.doi.org/10.1073/pnas.0901402106] [PMID: 19633196]
162. Li, L.Y.; Li, J.T.; Wu, Q.Y.; Li, J.; Feng, Z.T.; Liu, S.; Wang, T.H. Transplantation of NGF-gene-modified bone marrow stromal cells into a rat model of Alzheimer’ disease. J. Mol. Neurosci., 2008, 34 (2), 157-163. [http://dx.doi.org/10.1007/s12031-007-9022-x] [PMID: 18074108]
163. Park, D.; Yang, G.; Bae, D.K.; Lee, S.H.; Yang, Y.H.; Kyung, J.; Kim, D.; Choi, E.K.; Choi, K.C.; Kim, S.U.; Kang, S.K.; Ra, J.C.; Kim, Y.B. Human adipose tissue-derived mesenchymal stem cells improve cognitive function and physical activity in ageing mice. J. Neurosci. Res., 2013, 91(5), 660-670. [http://dx.doi.org/10.1002/jnr.23182] [PMID: 23404260]
164. Ryu, J.K.; Cho, T.; Wang, Y.T.; McLarnon, J.G. Neural progenitor cells attenuate inflammatory reactivity and neuronal loss in an animal model of inflamed AD brain. J. Neuroinflammation, 2009, 6, 39. [http://dx.doi.org/10.1186/1742-2094-6-39] [PMID: 20030829]
165. Martino, G.; Pluchino, S.; Bonfanti, L.; Schwartz, M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol. Rev., 2011, 91(4), 1281-1304. [http://dx.doi.org/10.1152/physrev.00032. 2010] [PMID: 22013212]
166. Lee, J.K.; Jin, H.K.; Endo, S.; Schuchman, E.H.; Carter, J.E.; Bae, J.S. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer’s disease mice by modulation of immune responses. Stem Cells, 2010, 28(2), 329-343. [PMID: 20014009]
167. Lee, H.J.; Lee, J.K.; Lee, H.; Carter, J.E.; Chang, J.W.; Oh, W.; Yang, Y.S.; Suh, J.G.; Lee, B.H.; Jin, H.K.; Bae, J.S. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer’s disease mouse model through modulation of neuroinflammation. Neurobiol. Aging, 2012, 33(3), 588-602. [http://dx.doi.org/10. 1016/j.neurobiolaging.2010.03.024] [PMID: 20471717]
168. Lee, J.K.; Schuchman, E.H.; Jin, H.K.; Bae, J.S. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer’s disease in mice by recruiting bone marrow-induced microglia immune responses. Stem Cells, 2012, 30(7), 1544-1555. [http://dx.doi.org/10.1002/stem.1125] [PMID: 22570192]
169. Takata, K.; Kitamura, Y.; Yanagisawa, D.; Morikawa, S.; Morita, M.; Inubushi, T.; Tsuchiya, D.; Chishiro, S.; Saeki, M.; Taniguchi, T.; Shimohama, S.; Tooyama, I. Microglial transplantation increases amyloid-beta clearance in Alzheimer model rats. FEBS Lett., 2007, 581(3), 475-478. [http://dx.doi.org/10.1016/j.febslet. 2007.01.009] [PMID: 17240371]
170. Hickman, S.E.; Allison, E.K.; El Khoury, J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice. J. Neurosci., 2008, 28(33), 8354-8360. [http://dx.doi. org/10.1523/JNEUROSCI.0616-08.2008] [PMID: 18701698]
171. Lee, J.K.; Jin, H.K.; Bae, J.S. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer’s disease mouse model. Neurosci. Lett., 2009, 450(2), 136-141. [http://dx. doi.org/10.1016/j.neulet.2008.11.059] [PMID: 19084047]
172. Giunti, D.; Parodi, B.; Usai, C.; Vergani, L.; Casazza, S.; Bruzzone, S.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells, 2012, 30(9), 2044-2053. [http://dx.doi.org/10.1002/stem.1174] [PMID: 22821677]
173. Fuhrmann, M.; Bittner, T.; Jung, C.K.; Burgold, S.; Page, R.M.; Mitteregger, G.; Haass, C.; LaFerla, F.M.; Kretzschmar, H.; Herms, J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat. Neurosci., 2010, 13(4), 411-413. [http://dx.doi.org/10.1038/nn.2511] [PMID: 20305648]
174. Kanno, H. Regenerative therapy for neuronal diseases with transplantation of somatic stem cells. World J. Stem Cells, 2013, 5(4), 163-171. [http://dx.doi.org/10.4252/wjsc.v5.i4.163] [PMID: 24179604]
175. Mu, Y.; Gage, F.H. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol. Neurodegener., 2011, 6, 85. [http://dx. doi.org/10.1186/1750-1326-6-85] [PMID: 22192775]
176. Enciu, A.M.; Nicolescu, M.I.; Manole, C.G.; Mureşanu, D.F.; Popescu, L.M.; Popescu, B.O. Neuroregeneration in neurodegenerative disorders. BMC Neurol., 2011, 11, 75. [http://dx.doi. org/10.1186/1471-2377-11-75] [PMID: 21699711]
177. Ganz, J.; Lev, N.; Melamed, E.; Offen, D. Cell replacement therapy for Parkinson’s disease: how close are we to the clinic?. Expert Rev. Neurother., 2011, 11(9), 1325-1339. [http://dx.doi.org/10.1586/ern.11.74] [PMID: 21864078]
178. Teixeira, F.G.; Carvalho, M.M.; Sousa, N.; Salgado, A.J. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell. Mol. Life Sci., 2013, 70(20), 3871-3882. [http://dx.doi.org/10.1007/s00018-013-1290-8] [PMID: 23456256]
179. Blandini, F.; Cova, L.; Armentero, M.T.; Zennaro, E.; Levandis, G.; Bossolasco, P.; Calzarossa, C.; Mellone, M.; Giuseppe, B.; Deliliers, G.L.; Polli, E.; Nappi, G.; Silani, V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant., 2010, 19(2), 203-217. [http://dx.doi.org/10.3727/096368909X479839] [PMID: 19906332]
180. McCoy, M.K.; Martinez, T.N.; Ruhn, K.A.; Wrage, P.C.; Keefer, E.W.; Botterman, B.R.; Tansey, K.E.; Tansey, M.G. Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson’s disease. Exp. Neurol., 2008, 210(1), 14-29. [http://dx.doi.org/10.1016/j.expneurol.2007.10.011] [PMID: 18061169]
181. Mathieu, P.; Roca, V.; Gamba, C.; Del Pozo, A.; Pitossi, F. Neuroprotective effects of human umbilical cord mesenchymal stromal cells in an immunocompetent animal model of Parkinson’s disease. J. Neuroimmunol., 2012, 246(1-2), 43-50. [http://dx.doi. org/10.1016/j.jneuroim.2012.03.004] [PMID: 22458982]
182. Danielyan, L.; Schafer, R.; von Ameln-Mayerhofer, A.; Bernhard, F.; Verleysdonk, S.; Buadze, M.; Lourhmati, A.; Klopfer, T.; Schaumann, F.; Schmid, B.; Koehle, C.; Proksch, B.; Weissert, R.; Reichardt, H.M.; van den Brandt, J.; Buniatian, G.H.; Schwab, M.; Gleiter, C.H.; Frey, W.H., II Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res., 2011, 14(1), 3-16. [http://dx.doi.org/10.1089/rej.2010.1130] [PMID: 21291297]
183. Wang, F.; Yasuhara, T.; Shingo, T.; Kameda, M.; Tajiri, N.; Yuan, W.J.; Kondo, A.; Kadota, T.; Baba, T.; Tayra, J.T.; Kikuchi, Y.; Miyoshi, Y.; Date, I. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha. BMC Neurosci., 2010, 11, 52. [http://dx.doi.org/10.1186/1471-2202-11-52] [PMID: 20420688]
184. Park, H.J.; Shin, J.Y.; Lee, B.R.; Kim, H.O.; Lee, P.H. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Cell Transplant., 2012, 21(8), 1629-1640. [http://dx.doi.org/10.3727/096368912X640556] [PMID: 22546197]
185. Trzaska, K.A.; Kuzhikandathil, E.V.; Rameshwar, P. Specification of a dopaminergic phenotype from adult human mesenchymal stem cells. Stem Cells, 2007, 25(11), 2797-2808. [http://dx.doi.org/10.1634/stemcells.2007-0212] [PMID: 17656644]
186. Somoza, R.; Juri, C.; Baes, M.; Wyneken, U.; Rubio, F.J. Intranigral transplantation of epigenetically induced BDNFsecreting human mesenchymal stem cells: implications for cellbased therapies in Parkinson’s disease. Biol. Blood Marrow Transplant., 2010, 16(11), 1530-1540. [http://dx.doi.org/10.1016/j.bbmt.2010.06.006] [PMID: 20542127]
187. Munoz, J.R.; Stoutenger, B.R.; Robinson, A.P.; Spees, J.L.; Prockop, D.J. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA, 2005, 102(50), 18171-18176. [http://dx.doi.org/10.1073/pnas.0508945102] [PMID: 16330757]
188. Xiao, L.; Tsutsui, T. Human dental mesenchymal stem cells and neural regeneration. Hum. Cell, 2013, 26(3), 91-96. [http://dx.doi. org/10.1007/s13577-013-0069-4] [PMID: 23817972]
189. Chao, Y.; Wong, S.C.; Tan, E.K. Evidence of inflammatory system involvement in Parkinson’s disease. Biomed. Res. Int., 2014, 2014, 308654. [http://dx.doi.org/10.1155/2014/308654]
190. Yan, J.; Fu, Q.; Cheng, L.; Zhai, M.; Wu, W.; Huang, L.; Du, G. Inflammatory response in Parkinson’s disease (Review). Mol. Med. Rep., 2014, 10(5), 2223-2233. [Review]. [PMID: 25215472]
191. Kim, Y.J.; Park, H.J.; Lee, G.; Bang, O.Y.; Ahn, Y.H.; Joe, E.; Kim, H.O.; Lee, P.H. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through antiinflammatory action. Glia, 2009, 57(1), 13-23. [http://dx.doi.org/10.1002/glia.20731] [PMID: 18661552]
192. Chao, Y.X.; He, B.P.; Tay, S.S. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson’s disease. J. Neuroimmunol., 2009, 216(1-2), 39-50. [http://dx.doi. org/10.1016/j.jneuroim.2009.09.003] [PMID: 19819031]
193. Mahmood, A.; Lu, D.; Wang, L.; Li, Y.; Lu, M.; Chopp, M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery, 2001, 49, 1196-1203. discussion 1203-1194
194. Mahmood, A.; Lu, D.; Lu, M.; Chopp, M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery, 2003, 53, 697-702. discussion 702-693 [http://dx.doi.org/10.1227/01.NEU. 0000079333.61863.AA]
195. Galindo, L.T.; Filippo, T.R.; Semedo, P.; Ariza, C.B.; Moreira, C.M.; Camara, N.O.; Porcionatto, M.A. Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol. Res. Int., 2011, 2011, 564089. [http://dx.doi.org/10.1155/2011/564089]
196. Chen, M.; Li, X.; Zhang, X.; He, X.; Lai, L.; Liu, Y.; Zhu, G.; Li, W.; Li, H.; Fang, Q.; Wang, Z.; Duan, C. The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6. J. Neuroinflammation, 2015, 12, 61. [http://dx.doi.org/10.1186/s12974-015-0284-x] [PMID: 25890011]
197. Baranova, N.S.; Nileback, E.; Haller, F.M.; Briggs, D.C.; Svedhem, S.; Day, A.J.; Richter, R.P. The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J. Biol. Chem., 2011, 286(29), 25675-25686. [http://dx. doi.org/10.1074/jbc.M111.247395] [PMID: 21596748]
198. Pati, S.; Khakoo, A.Y.; Zhao, J.; Jimenez, F.; Gerber, M.H.; Harting, M.; Redell, J.B.; Grill, R.; Matsuo, Y.; Guha, S.; Cox, C.S.; Reitz, M.S.; Holcomb, J.B.; Dash, P.K. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling. Stem Cells Dev., 2011, 20(1), 89-101. [http://dx.doi.org/10.1089/scd.2010.0013] [PMID: 20446815]
199. Torrente, D.; Avila, M.F.; Cabezas, R.; Morales, L.; Gonzalez, J.; Samudio, I.; Barreto, G.E. Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model. Hum. Exp. Toxicol., 2014, 33(7), 673-684. [http://dx.doi.org/10.1177/0960327113509659] [PMID: 24178889]
200. Bai, L.; Lennon, D.P.; Eaton, V.; Maier, K.; Caplan, A.I.; Miller, S.D.; Miller, R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia, 2009, 57(11), 1192-1203. [http://dx.doi.org/10.1002/glia.20841] [PMID: 19191336]
201. Torres-Espin, A.; Corona-Quintanilla, D.L.; Fores, J.; Allodi, I.; Gonzalez, F.; Udina, E.; Navarro, X. Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy. Neurotherapeutics, 2013, 10(2), 354-368. [http://dx.doi.org/10.1007/s13311-013-0178-5] [PMID: 23440700]
202. Azari, M.F.; Mathias, L.; Ozturk, E.; Cram, D.S.; Boyd, R.L.; Petratos, S. Mesenchymal stem cells for treatment of CNS injury. Curr. Neuropharmacol., 2010, 8(4), 316-323. [http://dx.doi.org/10. 2174/157015910793358204] [PMID: 21629440]
203. Rehman, J.; Traktuev, D.; Li, J.; Merfeld-Clauss, S.; Temm-Grove, C.J.; Bovenkerk, J.E.; Pell, C.L.; Johnstone, B.H.; Considine, R.V.; March, K.L. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 2004, 109(10), 1292-1298. [http://dx.doi.org/10.1161/01.CIR.0000121425.42966.F1] [PMID: 14993122]
204. Nakagami, H.; Maeda, K.; Morishita, R.; Iguchi, S.; Nishikawa, T.; Takami, Y.; Kikuchi, Y.; Saito, Y.; Tamai, K.; Ogihara, T.; Kaneda, Y. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler. Thromb. Vasc. Biol., 2005, 25(12), 2542-2547. [http://dx.doi.org/10.1161/01.ATV.0000190701.92007.6d] [PMID: 16224047]
205. Wei, X.; Du, Z.; Zhao, L.; Feng, D.; Wei, G.; He, Y.; Tan, J.; Lee, W.H.; Hampel, H.; Dodel, R.; Johnstone, B.H.; March, K.L.; Farlow, M.R.; Du, Y. IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells, 2009, 27(2), 478-488. [http://dx.doi.org/10.1634/stemcells.2008-0333] [PMID: 19023032]
206. Hawryluk, G.W.; Mothe, A.; Wang, J.; Wang, S.; Tator, C.; Fehlings, M.G. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev., 2012, 21(12), 2222-2238. [http://dx.doi.org/10.1089/scd.2011.0596] [PMID: 22085254]
207. Lu, P.; Jones, L.L.; Tuszynski, M.H. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp. Neurol., 2007, 203(1), 8-21. [http://dx.doi.org/10.1016/j.expneurol.2006. 07.030] [PMID: 17014846]
208. Novikova, L.N.; Brohlin, M.; Kingham, P.J.; Novikov, L.N.; Wiberg, M. Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats. Cytotherapy, 2011, 13(7), 873-887. [http://dx.doi.org/10.3109/14653249.2011.574116] [PMID: 21521004]
209. Ohta, M.; Suzuki, Y.; Noda, T.; Ejiri, Y.; Dezawa, M.; Kataoka, K.; Chou, H.; Ishikawa, N.; Matsumoto, N.; Iwashita, Y.; Mizuta, E.; Kuno, S.; Ide, C. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol., 2004, 187(2), 266-278. [http://dx.doi.org/10.1016/j.expneurol.2004.01. 021] [PMID: 15144853]
210. Cizkova, D.; Novotna, I.; Slovinska, L.; Vanicky, I.; Jergova, S.; Rosocha, J.; Radonak, J. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J. Neurotrauma, 2011, 28(9), 1951-1961. [http://dx.doi.org/10.1089/neu.2010.1413] [PMID: 20822464]
211. Urdzikova, L.; Jendelova, P.; Glogarova, K.; Burian, M.; Hajek, M.; Sykova, E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J. Neurotrauma, 2006, 23(9), 1379-1391. [http://dx.doi.org/10.1089/neu.2006.23.1379] [PMID: 16958589]
212. Zurita, M.; Vaquero, J.; Bonilla, C.; Santos, M.; De Haro, J.; Oya, S.; Aguayo, C. Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells. Transplantation, 2008, 86(6), 845-853. [http://dx.doi.org/10.1097/TP.0b013e318186198f] [PMID: 18813110]
213. Deng, Y.B.; Liu, X.G.; Liu, Z.G.; Liu, X.L.; Liu, Y.; Zhou, G.Q. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy, 2006, 8(3), 210-214. [http://dx.doi.org/10.1080/14653240600760808] [PMID: 16793730]
214. Wright, K.T.; El Masri, W.; Osman, A.; Chowdhury, J.; Johnson, W.E. Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells, 2011, 29(2), 169-178. [http://dx.doi.org/10.1002/stem.570] [PMID: 21732476]
215. Han, D.; Wu, C.; Xiong, Q.; Zhou, L.; Tian, Y. Anti-inflammatory Mechanism of Bone Marrow Mesenchymal Stem Cell Transplantation in Rat Model of Spinal Cord Injury. Cell Biochem. Biophys., 2014. [PMID: 25388837]
216. Uccelli, A.; Benvenuto, F.; Laroni, A.; Giunti, D. Neuroprotective features of mesenchymal stem cells. Best Pract. Res. Clin. Haematol., 2011, 24(1), 59-64. [http://dx.doi.org/10.1016/j.beha.2011.01.004] [PMID: 21396593]
217. Neuhuber, B.; Timothy Himes, B.; Shumsky, J.S.; Gallo, G.; Fischer, I. Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations. Brain Res., 2005, 1035(1), 73-85. [http://dx.doi.org/10.1016/j.brainres.2004.11.055] [PMID: 15713279]
218. Abrams, M.B.; Dominguez, C.; Pernold, K.; Reger, R.; Wiesenfeld-Hallin, Z.; Olson, L.; Prockop, D. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restor. Neurol. Neurosci., 2009, 27(4), 307-321. [PMID: 19738324]
219. Tran, C.T.; Gargiulo, C.; Thao, H.D.; Tuan, H.M.; Filgueira, L.; Michael Strong, D. Culture and differentiation of osteoblasts on coral scaffold from human bone marrow mesenchymal stem cells. Cell Tissue Bank., 2011, 12(4), 247-261. [http://dx.doi.org/10.1007/s10561-010-9208-2] [PMID: 20703817]
220. Sakata, N.; Goto, M.; Yoshimatsu, G.; Egawa, S.; Unno, M. Utility of co-transplanting mesenchymal stem cells in islet transplantation. World J. Gastroenterol., 2011, 17(47), 5150-5155. [http://dx. doi.org/10.3748/wjg.v17.i47.5150] [PMID: 22215938]
221. Nakajima, H.; Uchida, K.; Guerrero, A.R.; Watanabe, S.; Sugita, D.; Takeura, N.; Yoshida, A.; Long, G.; Wright, K.T.; Johnson, W.E.; Baba, H. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J. Neurotrauma, 2012, 29(8), 1614-1625. [http://dx.doi.org/10.1089/neu.2011.2109] [PMID: 22233298]
222. Quertainmont, R.; Cantinieaux, D.; Botman, O.; Sid, S.; Schoenen, J.; Franzen, R. Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and proangiogenic actions. PLoS One, 2012, 7(6), e39500. [http://dx.doi. org/10.1371/journal.pone.0039500] [PMID: 22745769]
223. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 2005, 106(5), 1755-1761. [http://dx.doi.org/10.1182/blood-2005-04-1496] [PMID: 15905186]
224. Gharibi, T.; Ahmadi, M.; Seyfizadeh, N.; Jadidi-Niaragh, F.; Yousefi, M. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Cell. Immunol., 2015, 293(2), 113-121. [http://dx.doi.org/10.1016/j.cellimm.2015.01.002] [PMID: 25596473]
225. Rafei, M.; Campeau, P.M.; Aguilar-Mahecha, A.; Buchanan, M.; Williams, P.; Birman, E.; Yuan, S.; Young, Y.K.; Boivin, M.N.; Forner, K.; Basik, M.; Galipeau, J. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2- dependent manner. J. Immunol., 2009, 182(10), 5994-6002. [http://dx.doi.org/10.4049/jimmunol.0803962] [PMID: 19414750]
226. Zhang, X.; Bowles, A.C.; Semon, J.A.; Scruggs, B.A.; Zhang, S.; Strong, A.L.; Gimble, J.M.; Bunnell, B.A. Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model. PLoS One, 2014, 9(1), e85007. [http://dx.doi.org/10.1371/journal.pone.0085007] [PMID: 24465465]
227. Karussis, D.; Karageorgiou, C.; Vaknin-Dembinsky, A.; Gowda-Kurkalli, B.; Gomori, J.M.; Kassis, I.; Bulte, J.W.; Petrou, P.; Ben-Hur, T.; Abramsky, O.; Slavin, S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol., 2010, 67(10), 1187-1194. [http://dx.doi.org/10.1001/archneurol. 2010.248] [PMID: 20937945]
228. Connick, P.; Kolappan, M.; Patani, R.; Scott, M.A.; Crawley, C.; He, X.L.; Richardson, K.; Barber, K.; Webber, D.J.; Wheeler-Kingshott, C.A.; Tozer, D.J.; Samson, R.S.; Thomas, D.L.; Du, M.Q.; Luan, S.L.; Michell, A.W.; Altmann, D.R.; Thompson, A.J.; Miller, D.H.; Compston, A.; Chandran, S. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. Trials, 2011, 12, 62. [http://dx. doi.org/10.1186/1745-6215-12-62] [PMID: 21366911]
229. Connick, P.; Kolappan, M.; Crawley, C.; Webber, D.J.; Patani, R.; Michell, A.W.; Du, M.Q.; Luan, S.L.; Altmann, D.R.; Thompson, A.J.; Compston, A.; Scott, M.A.; Miller, D.H.; Chandran, S. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-ofconcept study. Lancet Neurol., 2012, 11(2), 150-156. [http://dx. doi.org/10.1016/S1474-4422(11)70305-2] [PMID: 22236384]
230. Hayashi, Y.; Tsuji, S.; Tsujii, M.; Nishida, T.; Ishii, S.; Iijima, H.; Nakamura, T.; Eguchi, H.; Miyoshi, E.; Hayashi, N.; Kawano, S. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J. Pharmacol. Exp. Ther., 2008, 326(2), 523-531. [http://dx.doi.org/10.1124/jpet.108.137083] [PMID: 18448866]
231. Tanaka, F.; Tominaga, K.; Ochi, M.; Tanigawa, T.; Watanabe, T.; Fujiwara, Y.; Ohta, K.; Oshitani, N.; Higuchi, K.; Arakawa, T. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci., 2008, 83(23-24), 771-779. [http://dx.doi.org/10.1016/j.lfs.2008.09.016] [PMID: 18950645]
232. Duijvestein, M.; Vos, A.C.; Roelofs, H.; Wildenberg, M.E.; Wendrich, B.B.; Verspaget, H.W.; Kooy-Winkelaar, E.M.; Koning, F.; Zwaginga, J.J.; Fidder, H.H.; Verhaar, A.P.; Fibbe, W.E.; van den Brink, G.R.; Hommes, D.W. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut, 2010, 59(12), 1662-1669. [http://dx.doi.org/10.1136/gut.2010.215152] [PMID: 20921206]
233. Lazebnik, L.B.; Konopliannikov, A.G.; Kniazev, O.V.; Parfenov, A.I.; Tsaregorodtseva, T.M.; Ruchkina, I.N.; Khomeriki, S.G.; Rogozina, V.A.; Konopliannikova, O.A. [Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases]. Ter. Arkh., 2010, 82(2), 38-43. [Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases]. [PMID: 20387674]
234. Garcia-Olmo, D.; Herreros, D.; Pascual, I.; Pascual, J.A.; Del-Valle, E.; Zorrilla, J.; De-La-Quintana, P.; Garcia-Arranz, M.; Pascual, M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis. Colon Rectum, 2009, 52(1), 79-86. [http://dx.doi.org/10.1007/DCR. 0b013e3181973487] [PMID: 19273960]
235. Ciccocioppo, R.; Bernardo, M.E.; Sgarella, A.; Maccario, R.; Avanzini, M.A.; Ubezio, C.; Minelli, A.; Alvisi, C.; Vanoli, A.; Calliada, F.; Dionigi, P.; Perotti, C.; Locatelli, F.; Corazza, G.R. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut, 2011, 60(6), 788-798. [http://dx.doi.org/10.1136/gut.2010.214841] [PMID: 21257987]
236. Miura, M.; Gronthos, S.; Zhao, M.; Lu, B.; Fisher, L.W.; Robey, P.G.; Shi, S. SHED: stem cells from human exfoliated deciduous teeth. Proc. Natl. Acad. Sci. USA, 2003, 100(10), 5807-5812. [http://dx.doi.org/10.1073/pnas.0937635100] [PMID: 12716973]
237. Seo, B.M.; Miura, M.; Gronthos, S.; Bartold, P.M.; Batouli, S.; Brahim, J.; Young, M.; Robey, P.G.; Wang, C.Y.; Shi, S. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet, 2004, 364(9429), 149-155. [http://dx. doi.org/10.1016/S0140-6736(04)16627-0] [PMID: 15246727]
238. Kadar, K.; Kiraly, M.; Porcsalmy, B.; Molnar, B.; Racz, G.Z.; Blazsek, J.; Kallo, K.; Szabo, E.L.; Gera, I.; Gerber, G.; Varga, G. Differentiation potential of stem cells from human dental origin - promise for tissue engineering. J. Physiol. Pharmacol., 2009, 60(Suppl. 7), 167-175. [PMID: 20388961]
239. Kadar, K.; Porcsalmy, B.; Kiraly, M.; Molnar, B.; Jobbagy-Ovari, G.; Somogyi, E.; Hermann, P.; Gera, I.; Varga, G. [Isolating, culturing and characterizing stem cells of human dental pulp origin]. Fogorv. Sz., 2009, 102(5), 175-181. [Isolating, culturing and characterizing stem cells of human dental pulp origin]. [PMID: 20000196]
240. Kiraly, M.; Porcsalmy, B.; Pataki, A.; Kadar, K.; Jelitai, M.; Molnar, B.; Hermann, P.; Gera, I.; Grimm, W.D.; Ganss, B.; Zsembery, A.; Varga, G. Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons. Neurochem. Int., 2009, 55(5), 323-332. [http://dx.doi.org/10.1016/j.neuint.2009.03.017] [PMID: 19576521]
241. Molnar, B.; Kadar, K.; Kiraly, M.; Porcsalmy, B.; Somogyi, E.; Hermann, P.; Grimm, W.D.; Gera, I.; Varga, G. [Isolation, cultivation and characterisation of stem cells in human periodontal ligament]. Fogorv. Sz., 2008, 101(4), 155-161. [Isolation, cultivation and characterisation of stem cells in human periodontal ligament]. [PMID: 19055131]
242. Varga, G.; Bori, E.; Kallo, K.; Nagy, K.; Tarjan, I.; Racz, G.Z. Novel possible pharmaceutical research tools: stem cells, gene delivery and their combination. Curr. Pharm. Des., 2013, 19(1), 133-141. [PMID: 22950495]
243. Li, X.Y.; Zheng, Z.H.; Li, X.Y.; Guo, J.; Zhang, Y.; Li, H.; Wang, Y.W.; Ren, J.; Wu, Z.B. Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomalies. Curr. Pharm. Des., 2013, 19(27), 4893-4899. [http://dx. doi.org/10.2174/13816128113199990326] [PMID: 23343120]
244. Tomar, G.B.; Srivastava, R.K.; Gupta, N.; Barhanpurkar, A.P.; Pote, S.T.; Jhaveri, H.M.; Mishra, G.C.; Wani, M.R. Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem. Biophys. Res. Commun., 2010, 393(3), 377-383. [http://dx.doi.org/10.1016/j.bbrc.2010.01.126] [PMID: 20138833]
245. Janebodin, K.; Horst, O.V.; Ieronimakis, N.; Balasundaram, G.; Reesukumal, K.; Pratumvinit, B.; Reyes, M. Isolation and characterization of neural crest-derived stem cells from dental pulp of neonatal mice. PLoS One, 2011, 6(11), e27526. [http://dx.doi. org/10.1371/journal.pone.0027526] [PMID: 22087335]
246. Musina, R.A.; Bekchanova, E.S.; Belyavskii, A.V.; Sukhikh, G.T. Differentiation potential of mesenchymal stem cells of different origin. Bull. Exp. Biol. Med., 2006, 141(1), 147-151. [http://dx.doi. org/10.1007/s10517-006-0115-2] [PMID: 16929987]
247. Sonoyama, W.; Liu, Y.; Yamaza, T.; Tuan, R.S.; Wang, S.; Shi, S.; Huang, G.T. Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J. Endod., 2008, 34(2), 166-171. [http://dx.doi.org/10.1016/j.joen. 2007.11.021] [PMID: 18215674]
248. Wada, N.; Menicanin, D.; Shi, S.; Bartold, P.M.; Gronthos, S. Immunomodulatory properties of human periodontal ligament stem cells. J. Cell. Physiol., 2009, 219(3), 667-676. [http://dx.doi.org/10.1002/jcp.21710] [PMID: 19160415]
249. Iwasaki, A.; Medzhitov, R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol., 2004, 5(10), 987-995. [http://dx.doi.org/10.1038/ni1112] [PMID: 15454922]
250. Kerkis, I.; Ambrosio, C.E.; Kerkis, A.; Martins, D.S.; Zucconi, E.; Fonseca, S.A.; Cabral, R.M.; Maranduba, C.M.; Gaiad, T.P.; Morini, A.C.; Vieira, N.M.; Brolio, M.P.; Sant’Anna, O.A.; Miglino, M.A.; Zatz, M. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J. Transl. Med., 2008, 6, 35. [http://dx.doi.org/10.1186/1479-5876-6-35] [PMID: 18598348]
251. Zhao, Y.; Wang, L.; Jin, Y.; Shi, S. Fas ligand regulates the immunomodulatory properties of dental pulp stem cells. J. Dent. Res., 2012, 91(10), 948-954. [http://dx.doi.org/10.1177/0022034512458690] [PMID: 22904205]
252. Akiyama, K.; Chen, C.; Wang, D.; Xu, X.; Qu, C.; Yamaza, T.; Cai, T.; Chen, W.; Sun, L.; Shi, S. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell, 2012, 10(5), 544-555. [http://dx.doi.org/10.1016/j.stem.2012.03.007] [PMID: 22542159]
253. Chassaing, B.; Aitken, J.D.; Malleshappa, M.; Vijay-Kumar, M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol., 2014, 104 Unit 15 25
254. Kim, H.S.; Kim, K.H.; Kim, S.H.; Kim, Y.S.; Koo, K.T.; Kim, T.I.; Seol, Y.J.; Ku, Y.; Rhyu, I.C.; Chung, C.P.; Lee, Y.M. Immunomodulatory effect of canine periodontal ligament stem cells on allogenic and xenogenic peripheral blood mononuclear cells. J. Periodontal Implant Sci., 2010, 40(6), 265-270. [http://dx.doi.org/10.5051/jpis.2010.40.6.265] [PMID: 21246016]
255. Ding, G.; Liu, Y.; An, Y.; Zhang, C.; Shi, S.; Wang, W.; Wang, S. Suppression of T cell proliferation by root apical papilla stem cells in vitro. Cells Tissues Organs (Print), 2010, 191(5), 357-364. [http://dx.doi.org/10.1159/000276589] [PMID: 20090301]
256. Liu, D.; Xu, J.; Liu, O.; Fan, Z.; Liu, Y.; Wang, F.; Ding, G.; Wei, F.; Zhang, C.; Wang, S. Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit impaired immunomodulation. J. Clin. Periodontol., 2012, 39(12), 1174-1182. [http://dx.doi.org/10.1111/jcpe.12009] [PMID: 23005571]
257. Arthur, A.; Rychkov, G.; Shi, S.; Koblar, S.A.; Gronthos, S. Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells, 2008, 26(7), 1787-1795. [http://dx.doi.org/10.1634/stemcells.2007-0979] [PMID: 18499892]
258. Kiraly, M.; Kadar, K.; Horvathy, D.B.; Nardai, P.; Racz, G.Z.; Lacza, Z.; Varga, G.; Gerber, G. Integration of neuronally predifferentiated human dental pulp stem cells into rat brain in vivo. Neurochem. Int., 2011, 59(3), 371-381. [http://dx.doi.org/10.1016/j.neuint.2011.01.006] [PMID: 21219952]
259. Leong, W.K.; Henshall, T.L.; Arthur, A.; Kremer, K.L.; Lewis, M.D.; Helps, S.C.; Field, J.; Hamilton-Bruce, M.A.; Warming, S.; Manavis, J.; Vink, R.; Gronthos, S.; Koblar, S.A. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl. Med., 2012, 1(3), 177-187. [http://dx.doi.org/10.5966/sctm.2011-0039] [PMID: 23197777]
260. Sakai, K.; Yamamoto, A.; Matsubara, K.; Nakamura, S.; Naruse, M.; Yamagata, M.; Sakamoto, K.; Tauchi, R.; Wakao, N.; Imagama, S.; Hibi, H.; Kadomatsu, K.; Ishiguro, N.; Ueda, M. Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuroregenerative mechanisms. J. Clin. Invest., 2012, 122(1), 80-90. [PMID: 22133879]
261. Arthur, A.; Shi, S.; Zannettino, A.C.; Fujii, N.; Gronthos, S.; Koblar, S.A. Implanted adult human dental pulp stem cells induce endogenous axon guidance. Stem Cells, 2009, 27(9), 2229-2237. [http://dx.doi.org/10.1002/stem.138] [PMID: 19544412]
262. Reichmann, F.; Painsipp, E.; Holzer, P. Environmental enrichment and gut inflammation modify stress-induced c-Fos expression in the mouse corticolimbic system. PLoS One, 2013, 8(1), e54811. [http://dx.doi.org/10.1371/journal.pone.0054811] [PMID: 23349972]
263. Mitrovic, M.; Shahbazian, A.; Bock, E.; Pabst, M.A.; Holzer, P. Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels. Br. J. Pharmacol., 2010, 160(6), 1430-1442. [http://dx.doi.org/10.1111/j.1476-5381.2010.00794.x] [PMID: 20590633]
264. Park, J.Y.; Jeon, S.H.; Choung, P.H. Efficacy of periodontal stem cell transplantation in the treatment of advanced periodontitis. Cell Transplant., 2011, 20(2), 271-285. [http://dx.doi.org/10.3727/096368910X519292] [PMID: 20719084]
265. Wu, T.; Liu, Y.; Fan, Z.; Xu, J.; Jin, L.; Gao, Z.; Wu, Z.; Hu, L.; Wang, J.; Zhang, C.; Chen, W.; Wang, S. miR-21 Modulates the Immunoregulatory Function of Bone Marrow Mesenchymal Stem Cells Through the PTEN/Akt/TGF-β1 Pathway. Stem Cells, 2015, 33(11), 3281-3290. [http://dx.doi.org/10.1002/stem.2081] [PMID: 26086742]
266. Aitken, J.D.; Gewirtz, A.T. Gut microbiota in 2012: Toward understanding and manipulating the gut microbiota. Nat. Rev. Gastroenterol. Hepatol., 2013, 10(2), 72-74. [http://dx.doi.org/10.1038/nrgastro.2012.252] [PMID: 23296245]
267. Ooi, J.H.; Waddell, A.; Lin, Y.D.; Albert, I.; Rust, L.T.; Holden, V.; Cantorna, M.T. Dominant effects of the diet on the microbiome and the local and systemic immune response in mice. PLoS One, 2014, 9(1), e86366. [http://dx.doi.org/10.1371/journal.pone. 0086366] [PMID: 24489720]
268. Duijvestein, M.; Wildenberg, M.E.; Welling, M.M.; Hennink, S.; Molendijk, I.; van Zuylen, V.L.; Bosse, T.; Vos, A.C.; de Jonge-Muller, E.S.; Roelofs, H.; van der Weerd, L.; Verspaget, H.W.; Fibbe, W.E.; te Velde, A.A.; van den Brink, G.R.; Hommes, D.W. Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells, 2011, 29(10), 1549-1558. [http://dx.doi.org/10.1002/stem.698] [PMID: 21898680]
269. Goncalves, Fda.C.; Schneider, N.; Pinto, F.O.; Meyer, F.S.; Visioli, F.; Pfaffenseller, B.; Lopez, P.L.; Passos, E.P.; Cirne-Lima, E.O.; Meurer, L.; Paz, A.H. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?. World J. Gastroenterol., 2014, 20(48), 18228-18239. [http://dx.doi.org/10.3748/wjg.v20.i48.18228] [PMID: 25561790]
270. He, X.W.; He, X.S.; Lian, L.; Wu, X.J.; Lan, P. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. Dig. Dis. Sci., 2012, 57(12), 3136-3144. [http://dx.doi.org/10.1007/s10620-012-2290-5] [PMID: 22752635]
271. Martinez-Montiel, Mdel.P.; Gomez-Gomez, G.J.; Flores, A.I. Therapy with stem cells in inflammatory bowel disease. World J. Gastroenterol., 2014, 20(5), 1211-1227. [http://dx.doi.org/10.3748/wjg.v20.i5.1211] [PMID: 24574796]
272. Tanaka, H.; Arimura, Y.; Yabana, T.; Goto, A.; Hosokawa, M.; Nagaishi, K.; Yamashita, K.; Yamamoto, H.; Sasaki, Y.; Fujimiya, M.; Imai, K.; Shinomura, Y. Myogenic lineage differentiated mesenchymal stem cells enhance recovery from dextran sulfate sodium-induced colitis in the rat. J. Gastroenterol., 2011, 46(2), 143-152. [http://dx.doi.org/10.1007/s00535-010-0320-7] [PMID: 20848145]
273. Nam, Y.S.; Kim, N.; Im, K.I.; Lim, J.Y.; Lee, E.S.; Cho, S.G. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World J. Gastroenterol., 2015, 21(7), 2030-2039. [PMID: 25717235]
274. Zhang, Z.; Han, Y.; Song, J.; Luo, R.; Jin, X.; Mu, D.; Su, S.; Ji, X.; Ren, Y.F.; Liu, H. Interferon-γ regulates the function of mesenchymal stem cells from oral lichen planus via indoleamine 2,3-dioxygenase activity. J. Oral Pathol. Med., 2015, 44(1), 15-27. [http://dx.doi.org/10.1111/jop.12224] [PMID: 25212102]
275. Sivanathan, K.N.; Gronthos, S.; Rojas-Canales, D.; Thierry, B.; Coates, P.T. Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev., 2014, 10(3), 351-375. [http://dx.doi.org/10.1007/s12015-014-9495-2] [PMID: 24510581]
276. English, K.; Barry, F.P.; Field-Corbett, C.P.; Mahon, B.P. IFNgamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett., 2007, 110(2), 91-100. [http://dx.doi.org/10.1016/j.imlet.2007.04.001] [PMID: 17507101]
277. Cuerquis, J.; Romieu-Mourez, R.; Francois, M.; Routy, J.P.; Young, Y.K.; Zhao, J.; Eliopoulos, N. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation. Cytotherapy, 2014, 16(2), 191-202. [http://dx.doi.org/10.1016/j.jcyt.2013.11.008] [PMID: 24438900]
278. Castelo-Branco, M.T.; Soares, I.D.; Lopes, D.V.; Buongusto, F.; Martinusso, C.A.; do Rosario, A., Jr; Souza, S.A.; Gutfilen, B.; Fonseca, L.M.; Elia, C.; Madi, K.; Schanaider, A.; Rossi, M.I.; Souza, H.S. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One, 2012, 7(3), e33360. [http://dx.doi.org/10.1371/journal.pone.0033360] [PMID: 22432015]
279. Anderson, P.; Souza-Moreira, L.; Morell, M.; Caro, M.; O’Valle, F.; Gonzalez-Rey, E.; Delgado, M. Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut, 2013, 62(8), 1131-1141. [http://dx.doi.org/10.1136/gutjnl-2012-302152] [PMID: 22637701]
280. Sun, T.; Gao, G.Z.; Li, R.F.; Li, X.; Li, D.W.; Wu, S.S.; Yeo, A.E.; Jin, B. Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice. Am. J. Transl. Res., 2015, 7(5), 891-901. [PMID: 26175850]
281. Chen, Y.; Song, Y.; Miao, H.; Xu, Y.; Lv, M.; Wang, T.; Hou, Y. Gene delivery with IFN-γ-expression plasmids enhances the therapeutic effects of MSCs on DSS-induced mouse colitis. Inflamm. Res., 2015, 64(9), 671-681. [http://dx.doi.org/10.1007/s00011-015-0845-6] [PMID: 26153869]